Bracebridge Capital, LLC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217109. A total of 31 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bracebridge Capital, LLC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q1 2023$524,000
+2.7%
50,0000.0%0.14%
+191.7%
Q4 2022$510,000
+1.4%
50,0000.0%0.05%
-46.1%
Q3 2022$503,0000.0%50,0000.0%0.09%
+11.2%
Q2 2022$503,000
+0.8%
50,0000.0%0.08%
+116.2%
Q1 2022$499,000
-0.2%
50,0000.0%0.04%
+19.4%
Q4 2021$500,00050,0000.03%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q1 2022
NameSharesValueWeighting ↓
RAMIUS ADVISORS LLC 396,766$3,968,0001.39%
Telemetry Investments, L.L.C. 75,500$755,0000.97%
FIFTH LANE CAPITAL, LP 102,500$1,025,0000.60%
CANTOR FITZGERALD, L. P. 680,000$6,800,0000.48%
MMCAP International Inc. SPC 650,000$6,500,0000.40%
Wealthspring Capital LLC 184,670$1,848,0000.40%
HGC Investment Management Inc. 500,000$5,000,0000.31%
Atalaya Capital Management LP 250,000$2,500,0000.24%
Lynwood Capital Management Inc. 25,000$250,0000.24%
MANGROVE PARTNERS IM, LLC 400,000$4,000,0000.24%
View complete list of BIOPLUS ACQUISITION CORP shareholders